Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
C 3.16 12.46% 0.35
EARS closed up 12.46 percent on Friday, March 5, 2021, on 12.34 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical EARS trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Crossed Above 50 DMA Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Older End-of-Day Signals for EARS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Auris Medical Holding AG Description

Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Products Symptoms Drug Delivery Hearing Nervous System Perception Hearing Loss Novel Products Auditory System Sensorineural Hearing Loss Tinnitus Drug Delivery Devices Inner Ear

Is EARS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.6
52 Week Low 0.65
Average Volume 1,499,117
200-Day Moving Average 1.63
50-Day Moving Average 3.09
20-Day Moving Average 3.51
10-Day Moving Average 3.27
Average True Range 0.55
ADX 43.76
+DI 34.72
-DI 19.05
Chandelier Exit (Long, 3 ATRs ) 3.90
Chandelier Exit (Short, 3 ATRs ) 4.34
Upper Bollinger Band 4.37
Lower Bollinger Band 2.65
Percent B (%b) 0.29
BandWidth 48.98
MACD Line -0.01
MACD Signal Line 0.10
MACD Histogram -0.1123
Fundamentals Value
Market Cap 22.4 Million
Num Shares 7.09 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -2.38
Price-to-Sales 0.00
Price-to-Book 1.37
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.29
Resistance 3 (R3) 5.37 4.75 4.94
Resistance 2 (R2) 4.75 4.20 4.71 4.82
Resistance 1 (R1) 3.95 3.87 4.35 3.87 4.70
Pivot Point 3.33 3.33 3.53 3.29 3.33
Support 1 (S1) 2.53 2.78 2.93 2.45 1.62
Support 2 (S2) 1.91 2.45 1.87 1.50
Support 3 (S3) 1.11 1.91 1.39
Support 4 (S4) 1.03